REVERSAL OF DIRECT FACTOR XA INHIBITORS WITH ANDEXANET ALFA PRIOR TO INVASIVE OR SURGICAL PROCEDURES

被引:0
|
作者
Bradshaw, Paige [1 ]
Philpott, Carolyn [1 ]
Droege, Christopher [1 ]
Droege, Molly [2 ]
Ernst, Neil [1 ]
Foertsch, Madeline [1 ]
Harger, Nicole [2 ]
Srinivasan, Vasisht [3 ]
Winter, Jessica [1 ]
Keegan, Shaun [1 ]
机构
[1] Univ Cincinnati, Med Ctr, Cincinnati, OH 45267 USA
[2] Univ Cincinnati, Med Ctr, UC Hlth, Cincinnati, OH 45267 USA
[3] Univ Washington, Sch Med, Seattle, WA 98195 USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
908
引用
收藏
页码:450 / 450
页数:1
相关论文
共 50 条
  • [1] Andexanet alfa for the reversal of factor Xa inhibitors
    Favresse, J.
    Hardy, M.
    van Dievoet, M. A.
    Sennesael, A. L.
    Douxfils, J.
    Samama, C. M.
    Vornicu, O.
    Dincq, A. S.
    Lessire, S.
    Mullier, F.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (05) : 387 - 397
  • [2] Reversal of apixaban and rivaroxaban with andexanet alfa prior to invasive or surgical procedures
    Bradshaw, Paige Garber
    Keegan, Shaun Patrick
    Droege, Molly Elizabeth
    Dykes, Nicole Jade Harger
    Ernst, Neil Edward
    Foertsch, Madeline Jane
    Makley, Amy Teres
    Mueller, Eric William
    Philpott, Carolyn Dosen
    Srinivasan, Vasisht
    Winter, Jessica Brooke
    Goodman, Michael D.
    Droege, Christopher Allen
    PHARMACOTHERAPY, 2022, 42 (10): : 780 - 791
  • [4] Andexanet alfa for reversal of factor Xa inhibitors: a critical review of the evidence
    Abdulrehman, Jameel
    Eikelboom, John W.
    Siegal, Deborah M.
    FUTURE CARDIOLOGY, 2019, 15 (06) : 395 - 404
  • [5] Andexanet Alfa for Factor Xa Inhibitor Reversal
    Shatzel, Joseph J.
    Daughety, Molly M.
    DeLoughery, Thomas G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (25): : 2499 - 2499
  • [6] Measuring residual anti-Xa activity of direct factor Xa inhibitors after reversal with andexanet alfa
    Bourdin, Matthieu
    Perrotin, Delphine
    Mathieu, Olivier
    Herve, Tristan
    Depasse, Francois
    Lu, Genmin
    Conley, Pamela B.
    Contant, Genevieve
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2021, 43 (04) : 795 - 801
  • [7] Andexanet Alfa for Bleeding with Factor Xa Inhibitors
    Ponnusamy, Vignesh
    Sinha, Ankur
    Kupfer, Yizhak
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (02): : 191 - 192
  • [8] Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity
    Siegal, Deborah M.
    Curnutte, John T.
    Connolly, Stuart J.
    Lu, Genmin
    Conley, Pamela B.
    Wiens, Brian L.
    Mathur, Vandana S.
    Castillo, Janice
    Bronson, Michele D.
    Leeds, Janet M.
    Mar, Florie A.
    Gold, Alex
    Crowther, Mark A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (25): : 2413 - 2424
  • [9] Utilization and Laboratory Monitoring of Andexanet Alfa Reversal of Factor Xa Inhibitors in Bleeding Patients
    Alipour, Zahra
    Jackups, Ronald
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2020, 154 : S17 - S18
  • [10] COMPARISON OF ANDEXANET ALFA AND 4-FACTOR PROTHROMBIN COMPLEX FOR REVERSAL OF FACTOR XA INHIBITORS
    Stevens, Victoria
    Kiser, Tyree
    MacLaren, Robert
    Reynolds, Paul
    Trujillo, Toby
    Mueller, Scott
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 298 - 298